Cancer Profiling and Pathways: Technologies and Global Markets

Publisher Name :
Date: 25-Mar-2019
No. of pages: 255

Report Scope:

Cancer biomarkers have gained significant importance in the drug-development process, and the market is an emerging segment. To gain an understanding of the market dynamics, market size and competitive landscape, a detailed analysis of cancer biomarker market and cancer profiling technologies and new developments is needed. Microarray technologies provide analysis of tens of thousands of molecules for a variety of assays, including drug binding, molecular interactions, enzyme activity and pathway identification. These microarrays, which include DNA microarrays, protein microarrays, tissue microarrays, low complexity microarrays and carbohydrate microarrays, are excellent tools for gene expression profiling, biomarker profiling and diagnostics.?

Pharmaceutical and biotechnology researchers use microarrays to streamline drug target identification, selection, validation and predictive testing. Rapid growth in the clinical research and diagnostic devices markets holds great potential for applications of microarray technology, including basic research, clinical trials and diagnostic devices. This report examines various microarray platforms and the technologies that are utilized to detect DNA and proteins for the purpose of drug discovery, disease diagnosis and disease monitoring. This report also examines companies that are actively developing and marketing microarray instrumentation or microarray biochips.

The report categorizes the biomarkers and profiling market and provides market data, market drivers, trends and opportunities, top-selling products, key players and competitive outlook. This report will also provide market tables and also provides company profiles.

This report analyzes the cancer profiling and pathways market: technologies market, tools market, and application market (diagnosis, drug development and discovery). This report also examines recent studies, microRNA detection and profiling, clinically oriented microRNA profiling in several human cancers. The report covers epigenetic, methylation and miRNA products in development, products in clinical trials, currently marketed and clinical-stage development products. Relationship between miRNAs and epigenetics is also examined. This report categorizes the market for epigenetics, forecasting the market value in revenue by analyzing the current and future trends in research, diagnostics and therapeutics industries. This report also looks at SNPs analysis instruments, reagents, software and services, providing information critical to understanding the business behind this new technology.

The following technologies and segments are excluded from this report: detailed instruments, pharmacogenomics, combinatorial chemistry, biochip, bioinformatics and high-throughput screening (HTS). Uses of emerging technologies in drug discovery such as lab-on-a-chip (LOAC), nanotechnology, and RNA interference (RNAi) also are not discussed here.

Report Includes:

- 91 tables

- An overview of the global market for cancer profiling and pathways

- Analyses of global market trends, with data from 2017 and 2018, and projections of compound annual growth rates (CAGRs) through 2023

- Discussion of products in this market, newly emerging tools, diagnostics and therapeutics, and their impacts on the market

- Examination of evolving methods, such as microarray analysis, multiplex PCR, and quantitative real-time PCR, which are integral to deciphering molecular mechanisms involved in gene function, biological development, and disease progression, and are important tools in the discovery and development of new drug targets and diagnostic biomarkers

- Identification of important cancer profiling techniques, market shares by types of products on the market, and market shares by company, as well as types of cancers and biomarkers

- Coverage of epigenetic, methylation, and miRNA products in development, products in clinical trials and currently marketed, and clinical-stage development products

- Company profiles of key players in the market

Summary

The global healthcare industry is undergoing key developments, advanced point-of-care diagnostics, availability of cost-effective treatment modalities and personalized medicine, which not only offers efficient early stage diagnosis, while also treating cancer conditions in order to reduce the overall healthcare cost and disease burden. This is one technology which has the potential to revolutionize cancer therapeutics and diagnostics in the healthcare sector.

An effective management and administration of targeted therapeutics and monitoring of cancer condition requires frequent profiling of patient's tumor mutations. Currently, the profiling of cancer has become very critical for cancer diagnosis, clinical trials, research and drug development efforts. With the launch of novel and efficacious targeted therapies that are developed and approved, profiling of tumors will become essential for therapy, patient selection and monitoring.

It is critical to understand the multivariate nature of cancer is and drug response also depends on molecular profiling at genetic, epigenetic and protein levels. Biomarkers, as defined by the National Institutes of Health (NIH), are "characteristics that are objectively measured and evaluated as an indicator of normal biologic processes, pathogenic processes, or pharmacologic responses to a therapeutic intervention." A biomarker has to be reliable, measurable, specific and predicative.

Cancer is a highly heterogenous disease involving dysregulation of multiple pathways regulating many fundamental cell processes such as growth, death, proliferation, differentiation and migration. Minor differences and subtle feedback nuances such as tumor microenvironments and endocrine feedback loops, often translate into major differences between cancers, and between patients who have the same cancers. These activities of molecular networks that orchestrate metabolic or cytoskeletal processes, or harmonize these by signal transduction, are altered in a complex manner by many genetic mutations in concert with the environmental context. The challenge is to understand these multivariate

dysregulations, with respect to both to how it arises from diverse genetic mutations and to how it can be treated. High-throughput experimental platform technologies ranging from genomic sequencing to transcriptomic, proteomic and metabolomic profiling are now commonly used for molecular-level characterization of tumor cells and surrounding tissues.

The major causes of cancer are infection and chronic inflammation. In this report, a general overview of the connection between cancer profiling technologies and cancer is provided. A better insight of these connections can yield novel diagnostic, preventive, and therapeutic strategies to reduce the global cancer burden. Gene expression profiling methods enable the detection and measurement of multiple expressed gene transcripts in a single RNA sample. Newer and improved methods for microarray analysis, multiplex PCR and quantitative real-time PCR are integral to deciphering the molecular mechanisms involved in gene function, cancer development and disease progression, and are important

tools in the discovery and development of new drug targets and diagnostic biomarkers. Innovative tools and techniques for sequencing and tumor profiling are growing and may represent excellent opportunities for life science suppliers.

Cancer Profiling and Pathways: Technologies and Global Markets

Table of Contents

Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing the Study
Scope of Report
Intended Audience
Methodology
Information Sources
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports

Chapter 2 Summary and Highlights
Cancer Profiling and Pathways

Chapter 3 Overview
Introduction
Biomarkers
Guidelines
Screening Tests
Early Detection and Diagnosis of Cancer
Pathway Profiling
Linking Cancer Disease through Pathway Profiling
Molecular Profiling
Historical Facts
Molecular Profiles
Cancer Profiling
Challenges
Clinical Utility of Molecular Profiling
Pathological Classification
Molecular Profiling Approaches
Cancer Profiling: Future Goals

Chapter 4 Current Profiling Techniques
Genomics
Genomic Profiling
Microarrays
Comparative Genomic Hybridization (CGH)
Key Companies
Key Players
Microarrays to Clinical Problems
Single Nucleotide Polymorphism (SNP)
Multi-color FISH
Companies
DNA Sequencing
Emerging DNA Sequencing Technologies
High-throughput Sequencing
Other Sequencing Technologies
Cancer Applications
Next-Gen Sequencing
Next-Generation Companies
ABI/SOLiD
Other Methods
Patents and Sequencing
Summary
Next-Generation Sequencing Technologies
Next-Generation Sequencing: Future
Genomics and Cancer—Some Examples
Mutations Predicting Resistance to Targeted Therapies
Sequencing and the Clinic
Transcriptomic Profiling
Microarray-based Gene Expression Profiling
Tiling Arrays
qRT-PCR
Cancer Applications
Emerging Microarray Technologies
Future

Chapter 5 Epigenomic Profiling
Overview and Introduction to the Epigenetics Landscape
Cancer Applications
DNA Methylation
microRNA
Epigenetic Changes and Cancer Stem Cells
Epigenetic Therapy for Cancer
Leading Epigenetic Companies
Epigenetics and MicroRNA Profiling—Finding Pathways to Treatment
MicroRNAs and Therapeutic Applications in Cancer
MicroRNAs as Prognostic and Therapeutic Biomarkers
Anti-Cancer Drugs and microRNA Targets
Case Study: Epigenetic Silencing of the Intronic microRNA Mir-342 in Colorectal Cancer
Diagnostic and Therapeutic microRNA Strategies in Cancer
Therapeutic Potential
Therapeutic Strategies
MicroRNAs in Disease Diagnostics
Circulating microRNAs
MicroRNA Profiling Methods
Clinical microRNA Diagnostics
MicroRNAs in Therapeutics
MicroRNA Patents and Outlook
Future
Methylation Markers
DNA Methylation, an Epigenetic Process
Current Methods and Products
Clinical Implications
Future Directions
Epigenetic Diagnostic Development
Epigenetic Drugs
HDAC Inhibitors
Epigenetic Therapeutic Development
Key Players

Chapter 6 Proteomics
Proteomics and Protein Profiling
Proteomics Protein Profiling Approaches
Techniques
Applications of Proteomic Techniques in Cancer Research
Technologies and Limitations
Proteomics and Initiatives
Cancer Applications
Proteomics in the Treatment of Cancer
Clinical Applications of Proteomics
Proteomic Approaches in Therapeutic Targets
Key Players
Proteomics-Based Diagnostic Products
Proteomic Research Centers
Clinical Trial Using Proteomics Technologies for Personalized Medicine
Proteomics and Medicine
Proteomics Market

Chapter 7 Glycomics
What is Glycomics?
Techniques
Analytical High-Throughput Technologies
Emergence of Glycoarrays
Glycoinformatics
Biomedical Applications
Glycomics's Relationship with Other "Omics" Technologies
Glycomics for Biomarker Discovery
Cancer and Glycomics
Glycomics-Biomarkers for Ovarian Cancer
U.S. Patents on Glycomics

Chapter 8 Metabolomics
What is Metabolomics?
Metabolome
Techniques
Detection Methods
Metabolomics and Drug Discovery
Biomarker Identification

Chapter 9 Bioinformatics, Databases and Pathway Analysis

Chapter 10 Cancer Profiling and Clinical Development
Biomarkers
Cancer and Biomarkers

Chapter 11 Market
Global DNA Diagnostics Market
The Cancer Diagnostics Market
Cancer Diagnostic Tests
The Cancer/Tumor Profiling Market
Personalized Medicine
Cancer Biomarker Testing Market
Genomics Market
SNP Genotyping and Analysis Market
Microarray/Biochips Market
Diagnostic Microarrays
DNA Sequencing Market
PCR Market
Epigenetics and Market
miRNA Market
Epigenetics and Cancer Market and Future Growth
Proteomics in the Pharma Industry
Protein Microarrays and Trends
The Metabolomics Market
Future
Conclusion

List of Tables
Summary Table : Global Cancer Profiling Technologies Market, by Type, Through 2023
Table 1 : Technical Approaches for Tumor Molecular Profiling
Table 2 : Different Tools for Molecular Profiling of Cancer
Table 3 : Genomics: Technologies
Table 4 : Applications Market
Table 5 : Segment Types
Table 6 : List of Techniques/Tools for Genomic Profiling
Table 7 : Global Genomics Market for Cancer Profiling Technologies, Through 2023
Table 8 : Commonly Used DNA Microarrays
Table 9 : Genomic Tests
Table 10 : Selected Companies with Microarray Technologies
Table 11 : Key Companies
Table 12 : Companies with Sequencing Technologies Next-Generation Sequencers
Table 13 : Sequencing Patents Awarded
Table 14 : Mutations Identified in Cancer
Table 15 : Consortium Listed Responsibilities
Table 16 : Transcriptomic Techniques
Table 17 : miRNA and siRNA-a Comparison
Table 18 : Epigenetic Drugs Approved by the U.S. FDA
Table 19 : HDAC Inhibitors
Table 20 : Selected Epigenetic Companies
Table 21 : Currently Used microRNA Techniques
Table 22 : MicroRNA Expression in Cancer
Table 23 : Epi-miRNAs Regulating Effectors of the Epigenetic Machinery
Table 24 : List of Predicted Targets That are Known Genes Affected in Colon Cancer
Table 25 : List of Predicted Targets That are Known Genes Affected in Pancreatic Cancer
Table 26 : miRNAs Differentially Expressed Between CRC and Normal Colorectal Tissue
Table 27 : miRNAs Differentially Expressed Between Normal Colon and Early-Stage Colorectal Cancer (Stages I and II)
Table 28 : miRNAs Differentially Expressed in Early- (I and II) Vs Late-Stage (III and IV) Disease
Table 29 : Pathways Targeted by CRC miRNAs
Table 30 : MicroRNAs as Prognostic Indicators and Therapeutic Targets: Potential Effect on Breast Cancer Management
Table 31 : MicroRNAs (miRs) with Altered Expression in Ovarian Carcinoma
Table 32 : MicroRNA-based Therapeutics: Development Status
Table 33 : Selected microRNAs in Development and Cancer
Table 34 : microRNA Patents
Table 35 : Global microRNA Market for Cancer Profiling Technologies, Through 2023
Table 36 : Selected Companies for miRNA-Specific Tools and Reagents
Table 37 : Intrinsic Classification of Breast Cancer, by Gene Expression Profiles and Cell Surface Hormonal Expression
Table 38 : Select Epigenetic-based Diagnostic Companies
Table 39 : Selected Methylation Tests for Cancer
Table 40 : Global Epigenetics Market for Cancer Profiling Technologies, Through 2023
Table 41 : Epigenetic Drugs for Cancer-Approved/Late-Stage Clinical Trials
Table 42 : Methylation Markers in Development
Table 43 : Selected Companies with Methylation Products
Table 44 : Methylation Markers/Tests-Patents
Table 45 : Biomarker Identified Using Two-Dimensional Electrophoresis (2-DE)
Table 46 : Biomarker Identified using Mass Spectroscopy (MS)
Table 47 : Antibody Array Vendors
Table 48 : Global Proteomics Market for Cancer Profiling Technologies, Through 2023
Table 49 : The Seven Tumor Glycome Laboratories
Table 50 : Clinical Trials and Glycomics
Table 51 : U.S. Patents on Glycomics
Table 52 : Key Predictive Biomarkers for Trastuzumab Therapy
Table 53 : Predictive Biomarkers for EGFR TKI Therapies in Lung Cancer
Table 54 : Global DNA Diagnostics Market, Through 2023
Table 55 : Cancer Profiling Market: Segment Types
Table 56 : Global Cancer Profiling Technologies Market, Through 2023
Table 57 : Cancer Profiling Market: Applications
Table 58 : Cancer Profiling Market: Technologies
Table 59 : Global Biomarkers Market, Through 2023
Table 60 : Selected Players
Table 61 : U.S. Biomarker Cancer Testing Market, Through 2023
Table 62 : Global Genomics Market for Cancer Profiling Technologies, Through 2023
Table 63 : Global SNP Genotyping Market, Through 2023
Table 64 : Global Biochips Market, Through 2023
Table 65 : Microarray Markets
Table 66 : Some Major BioChip Companies
Table 67 : Microarrays: Modalities
Table 68 : Global Diagnostic Microarray Market for Cancer Profiling Technologies, Through 2023
Table 69 : Some Commercially Available Cancer Diagnostic Devices Based on Microarray Technology
Table 70 : Microarray Technologies: Key Companies and Products
Table 71 : Global DNA Microarray Market, Through 2023
Table 72 : MicroArray Products
Table 73 : Global Next-Generation Sequencing Market, Through 2023
Table 74 : The Next-Generation Sequencing (NGS) Market: Platforms
Table 75 : Next-Generation Sequencing-Based Target Enrichment Industry Company Platform Method
Table 76 : Noninvasive Prenatal Diagnostics Potential Future Competitors
Table 77 : Global Polymerase Chain Reaction Market, Through 2023
Table 78 : Key PCR Companies
Table 79 : Real-Time (QRTPCR) PCR Selected Companies
Table 80 : Global Digital (d)PCR and qPCR Market, Through 2023
Table 81 : Global Epigenetics Market, Through 2023
Table 82 : Epigenetics Arrays and Selected Cancer Profiling Companies
Table 83 : Epigenetic Drugs: Approved by the FDA and Commercially Available
Table 84 : Epigenetics and Selected Companies
Table 85 : Epigenetic Diagnostic Tests
Table 86 : Global miRNA Market for Cancer Profiling Technologies, Through 2023
Table 87 : miRNA Market Segments
Table 88 : Selected Companies with Methylation Products
Table 89 : Global Proteomics Market for Cancer Profiling Technologies, Through 2023
Table 90 : Selected Companies Offering, Developing or Partnering to Develop Companion Diagnostics

List of Figures
Summary Figure : Global Cancer Profiling Technologies Market, by Type, 2017-2023
Figure 1 : Global Genomics Market for Cancer Profiling Technologies, 2017-2023
Figure 2 : Global microRNA Market for Cancer Profiling Technologies, 2017-2023
Figure 3 : Global Epigenetics Market for Cancer Profiling Technologies, 2017-2023
Figure 4 : Global Proteomics Market for Cancer Profiling Technologies, 2017-2023
Figure 5 : Global DNA Diagnostics Market, 2017-2023
Figure 6 : Global Biomarkers Market, 2017-2023
Figure 7 : U.S. Biomarker Cancer Testing Market, 2017-2023
Figure 8 : Global Genomics Market for Cancer Profiling Technologies, 2017-2023
Figure 9 : Global SNP Genotyping Market, 2017-2023
Figure 10 : Global Biochips Market, 2017-2023
Figure 11 : Global Diagnostic Microarray Market for Cancer Profiling Technologies, 2017-2023
Figure 12 : Global DNA Microarray Market, 2017-2023
Figure 13 : Global Next-Generation Sequencing Market, 2017-2023
Figure 14 : Global Polymerase Chain Reaction Market, 2017-2023
Figure 15 : Global Digital (d)PCR and qPCR Market, 2017-2023
Figure 16 : Global Epigenetics Market, 2017-2023
Figure 17 : Global miRNA Market for Cancer Profiling Technologies, 2017-2023
Figure 18 : Global Proteomics Market for Cancer Profiling Technologies, 2017-2023
  • Global Cytokine Inhibitor Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Cytokine Inhibitor market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The development prospects of cytokine inhibitors are very broad, and these drugs have many medical applications and researches. Cytokine inhibitors can reduce The activity of cytokines, thereby inhibiting their role in immune responses and reducing The activation of immune cells and The occurrence o......
  • Global Microbial Growth Media Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    Microbial Growth Media is a nutrient component required by microorganisms, containing a variety of trace elements and trace elements, such as copper, iron, zinc, cobalt, manganese, etc. The global Microbial Growth Media market was valued at US$ 8007 million in 2023 and is anticipated to reach US$ 11530 million by 2030, witnessing a CAGR of 5.3% during The forecast period 2024-2030. The market for microbial growth media is essential in microbiology and biotechnology rese......
  • Global Protein Biochip Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 92
    Protein Biochip is a small Protein array used to quickly detect a large number of unknown proteins. It works in a similar way to a DNA chip. First, a large number of known proteins (such as monoclonal antibodies) are placed on a small substrate and then exposed to and reacted with The unknown protein sample. Due to The specific binding between The antigen and The antibody, it can finally be detected by means of laser. The global Protein Biochip market was valued at US$ 145 million i......
  • Global Isothermal Nucleic Acid Amplification Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 103
    Isothermal nucleic acid amplification is referred to isothermal nucleic acid amplification technology. And in this report, we get The statistics on reagents used in isothermal nucleic acid amplification technology. Nucleic acid isothermal amplification is a newer technique that amplifies DNA or RNA specific fragment from few copies to billion-fold copies under a one temperature condition, unlike PCR amplification that needs at least 30-35 thermal cycles to accomplish The reaction. T......
  • Global Microfluidics Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 134
    According to our LPI (LP Information) latest study, the global Microfluidics market size was valued at US$ 3118.7 million in 2023. With growing demand in downstream market, the Microfluidics is forecast to a readjusted size of US$ 7707.1 million by 2030 with a CAGR of 13.8% during review period. The research report highlights the growth potential of the global Microfluidics market. Microfluidics are expected to show stable growth in the future market. However, product differentiation, re......
  • Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 122
    According to our LPI (LP Information) latest study, the global Isothermal Nucleic Acid Amplification Technology (INAAT) market size was valued at US$ 6141.3 million in 2023. With growing demand in downstream market, the Isothermal Nucleic Acid Amplification Technology (INAAT) is forecast to a readjusted size of US$ 11250 million by 2030 with a CAGR of 9.0% during review period. The research report highlights the growth potential of the global Isothermal Nucleic Acid Amplification Technol......
  • Global Cytokines Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 119
    According to our LPI (LP Information) latest study, the global Cytokines market size was valued at US$ 203730 million in 2023. With growing demand in downstream market, the Cytokines is forecast to a readjusted size of US$ 611910 million by 2030 with a CAGR of 17.0% during review period. The research report highlights the growth potential of the global Cytokines market. Cytokines are expected to show stable growth in the future market. However, product differentiation, reducing costs, an......
  • Global Western Blot Imagers Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94
    According to our LPI (LP Information) latest study, the global Western Blot Imagers market size was valued at US$ 406 million in 2023. With growing demand in downstream market, the Western Blot Imagers is forecast to a readjusted size of US$ 578.4 million by 2030 with a CAGR of 5.2% during review period. The research report highlights the growth potential of the global Western Blot Imagers market. Western Blot Imagers are expected to show stable growth in the future market. However, prod......
  • Global Procalcitonin Antibody Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 125
    According to our LPI (LP Information) latest study, the global Procalcitonin Antibody market size was valued at US$ million in 2023. With growing demand in downstream market, the Procalcitonin Antibody is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Procalcitonin Antibody market. Procalcitonin Antibody are expected to show stable growth in the future market. However, product di......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs